Fig. 7From: Efficacy and safety of mTOR inhibitors (rapamycin and its analogues) for tuberous sclerosis complex: a meta-analysisForest plot of the incident of nasopharyngitis in TSC patients with or without mTOR inhibitorsBack to article page